CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- 8-K Event Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 4 Grant or award Chief Financial Officer acquired 14,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Results of operations · Executive or director change · Regulation FD disclosure · Other events
- 4 Grant or award Director acquired 1,500 shares (grant or award)
- 4 Grant or award Director acquired 1,500 shares (grant or award)
- 4 Grant or award Director acquired 1,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 1,500 shares (grant or award)
- 4/A Grant or award Director acquired 1,500 shares (grant or award)
- 4 Derivatives Options or other derivatives
- EFFECT Other Notice of Effectiveness
- S-3/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Option exercise Chief Commercial Officer acquired 209 shares (option exercise)
- 8-K Event Regulation FD disclosure
Page 5 of 46 · 907 filings